Dr G Singh
Designation Scientist-B
Divsion Toxicology
Email singh[dot]drgyanendra[at]gov[dot]in
Contact +91-79-22688842

Academic Qualifications

  • Ph. D. (Toxicology) - CDRI, Lucknow & JNU, New Delhi
  • PDF (Molecular Biology) - USA

Membership/Fellowhips

  • American College of Toxicology (Ex Full sponsored membership)
  • American Society for Virology (Ex Nominated Associate membership)
  • American Society for Microbiology (Ex Contributing membership)
  • Indian Society for the Study of Reproduction and Fertility (Life membership)

Awards/Prize etc./Recoginitions

  • ICMR-IIT Kharagpur Med Tech Internship Award 2017
  • Prof. ‘GP Talwar Young Scientist Award’ at ISSRF 2017, organized by ICMR, New Delhi.
  • ABAP- 2015 ‘Young Scientist Award’ by Association of Biotechnology & Pharmacy at Guntur, A.P.
  • Awarded fellowship to attend ‘International Training on Environmental Toxicology’ at Bangkok, Thailand
  • Postdoctoral Researcher at LSU Health Sciences Center/Louisiana Vaccine Center & K-State, Manhattan, USA
  • Editor: Journal of Metabolomics and Systems Biology
  • Associate Editor: Universal Journal of Biotechnology & Bioinformatics
  • Lead Faculty – Toxicology; Virology – Webmedcentral, U.K.
  • Ex-Vice-President - LSU Health Sciences Center, Postdoctoral Association, New Orleans.
  • Marquis Who's Who in America 2011 Biography selected (65th Edition).
  • National Eligibility Test, CSIR - UGC (NET) - 2003.
  • National Eligibility Test, ASRB - ICAR (NET) - 2004.
  • Graduate Aptitude Test in Engineering (GATE) - 2002 with 92.39 Percentile, conducted by Indian Institute of Science, Bangalore.

Research Interest

  • Toxicology, Cancer biology, Infectious disease, Heavy metal toxicity

Human Resource Development

On Going

Submitted

Awarded

Ph. D.

01

 

01

M. Sc. Dissertation

-

-

10


Publications


  1. Sharma S, Dewan A and Singh G* (2017). Toxico-vigilance – An inevitable prerequisite to keep a watch on toxins around you. Journal of Forensic and Legal Medicine Jan; 45:32-35. 
  2. Sharma S, Kumar K and Singh G. (2017). An Overview on Narcotic Drugs and Psychotropic Substances Act, 1985. Journal of Forensic Sciences and Criminal Investigations, 4(4): 555644.
  3. Sharma S, Vasan D A and Singh G (2017). Dangers to the Environmental Health of Gujarat – A Forthcoming Industrial Hub of India. International Journal of Trend in Research and DevelopmentFeb; 4(1), ISSN: 2394-9333.
  4. Gao X, Pham TH, Feuerbacher LA, Chen K, Hays MP, Singh G, Rueter C, Guerrero RH, Hardwidge PR (2016). Citrobacter rodentium  NleB Inhibits Tumor Necrosis Factor (TNF) Receptor-Associated Factor 3 (TRAF3) Ubiquitination to Reduce Host Type I Interferon Production. Journal of Biological Chemistry. Aug 26;291(35):18232-8. 
  5. Shirish A, Kapadia V, Kumar S, Kumar S, Mishra, SD, Singh G (2016). Effectiveness of Cooling Jacket with Reference to Physiological Responses in Iron Foundry Workers. Journal of Occupational Safety and Ergonomics Dec;22(4):487-493)
  6. Singh G* and Sinha N (2016). An In-Vitro System to Assess Teratogenicity of Drugs / E Environmental Toxicants.  ISSRF Newsletter (18th edition) Feb; 31-33.
  7. Singh G*, Maurya R, Kumar A and Sinha N (2015). Role of Apoptosis in Mediating Diclofenac Induced Teratogenesis - An In Vitro Approach. Toxicology & Industrial Health 31(7) 614–623 
  8. Pham TH, Gao X, Singh G, Hardwidge PR (2013). Escherichia coli virulence protein NleH1 interaction with the v-crk sarcoma virus CT10 oncogene-Like protein (CRKL) governs NleH1 inhibition of the ribosomal protein S3 (RPS3)/NF-kappaB pathway. Journal of Biological Chemistry. Nov 29;288 (48):34567-74 
  9. Singh G*, Kumar A and Sinha N (2012). Studying Significance of Apoptosis in Mediating Tolbutamide Induced Teratogenesis In Vitro. Fundamental & Clinical Pharmacology Aug; 26(4): 484-94 
  10. Kelly B L, Singh G, and Aiyar A  (2011). Molecular and cellular characterization of an AT - hook protein from Leishmania. PLoS One (6(6): e21412 
  11. Washington A, Singh G and Aiyar A, (2010). Diametrically opposed effects of hypoxia and oxidative stress on two viral transactivators. Virology Journal May 10; 7:93 
  12. Singh G, Aras S, Zea AH, Koochekpour S and Aiyar A (2009). Optimal transactivation by Epstein-Barr nuclear antigen 1 requires the UR1 and ATH1 domains. Journal of Virology 83(9): 4227-4235. 
  13. Aras S, Singh G*, Johnston K, Foster T, Aiyar A (2009). Zinc-coordination is required for and regulates transcription activation by Epstein-Barr nuclear antigen 1. PLoS Pathogens (5(6):e1000469). 
  14. Aiyar A, Aras S, Washington A*Singh G* and Luftig R B (2009). Epstein-Barr Nuclear Antigen 1 modulates replication of oriP-plasmids by impeding replication and transcription fork migration through the family of repeats. Virology Journal Mar 5; 6:29. 
  15. Bhattacharjee PSNeumann DMFoster TPClement CSingh G, Thompson HW, Kaufman HEHill JM (2008). Effective treatment of ocular HSK with a human apolipoprotein E mimetic peptide in a mouse eye model. Investigative Ophthalmology and Visual Science Oct: 49(10):4263-8. 
  16. Shankar S, Singh G and Srivastava RK(2007).  Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential.  Frontiers in Bioscience,1(12):4839-54
  17. Bhadauria S, Singh G, Sinha N and Srivastava S. (2007). Isoniazid induces oxidative stress, mitochondrial dysfunction and apoptosis in Hep G2 cells. Cellular and Molecular Biology, 53: 102-14.
  18. Singh G, Sinha N, Koushik  JC, Mathur SK and Srivastava S (2005).  Detecting role of apoptosis in mediating cyclophosphamide induced teratogenesis in vitroToxicology Mechanisms and Methods, 15(6):391-7.